InvestSMART

Optiscan Imaging Limited (ASX:OIL)

ALERT: Price-sensitive ASX Announcement for OIL
Current share price for OIL : $0.160 -0.015 (-8.57%)+
Announcement
Release
25 Aug 2026 8:45AM
Price at Release
$0.175
Full Release
download
Summary
The Preliminary Final Report for Optiscan Imaging Limited for the financial year ending 30 June 2026 highlights a significant decrease in revenue from ordinary activities by 52.9% to $448,769, attributed to lower orders from Carl Zeiss Meditec and reduced sales of ViewnVivo. The company's loss after tax increased by 10.7% to $6,986,043, with no dividends declared. Despite this, net assets increased significantly due to a capital raise, resulting in cash inflow. The company continued to invest in research and development, focusing on refining their medical devices for clinical studies. Total expenses rose to $11,133,244 due to heightened R&D and commercial activities.
Key Points
  • Revenue from ordinary activities decreased by 52.9% to $448,769.
  • Loss after tax increased by 10.7% to $6,986,043.
  • No dividends were declared for the current financial period.
  • Net assets increased by $11,232,958 due to a successful capital raise.
  • Significant investment in R&D and commercial activities led to increased expenses.
  • Developments continued in producing medical devices for clinical use.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.